Back to LOS ANGELES CAPITAL MANAGEMENT LLC LOS ANGELES CAPITAL MANAGEMENT LLC

ARWRARWR
25 quarters

Position history for LOS ANGELES CAPITAL MANAGEMENT LLCLOS ANGELES CAPITAL MANAGEMENT LLC's holdings in ARROWHEAD PHARMACEUTICALS IN

LOS ANGELES CAPITAL MANAGEMENT LLC holds 578 shares of ARWR (ARROWHEAD PHARMACEUTICALS IN), worth $47,113 as of 2026-Q2. The position was decreased (-97.2% shares). ARWR represents 0.0% of LOS ANGELES CAPITAL MANAGEMENT LLC's portfolio.

Current Value

$47,113

Current Shares

578

Total Value Change

-$245,887

Total Shares Change

-15,402

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
578
-97.2%
$47,1130.0%$81.51
0
2026-Q1
Increased
20,970
+12.2%
$1.3M0.0%$64.10
28
2025-Q4
Unchanged
18,686
0.0%
$790,6050.0%$67.25
0
2025-Q3
Decreased
18,686
-67.8%
$644,4800.0%$33.78
0
2025-Q2
New
57,948
-
$915,5780.0%$16.08
34
2023-Q4
Exited
0
-100.0%
$00.0%$30.60
0
2023-Q3
Decreased
12,132
-19.1%
$325,9870.0%$26.87
0
2023-Q2
Increased
15,000
+76.3%
$534,9000.0%$35.93
37
2023-Q1
Decreased
8,510
-34.6%
$216,1540.0%$24.43
0
2022-Q4
Decreased
13,009
-7.8%
$527,6450.0%$40.56
0
2022-Q3
Increased
14,109
+11.0%
$466,0000.0%$33.28
27
2022-Q2
Increased
12,708
+43.6%
$447,0000.0%$34.56
32
2022-Q1
Increased
8,847
+4.7%
$407,0000.0%$45.59
25
2021-Q4
Increased
8,453
+1.6%
$560,0000.0%$67.35
25
2021-Q3
Decreased
8,323
-8.6%
$520,0000.0%$60.63
0
2021-Q2
Decreased
9,104
-56.1%
$754,0000.0%$81.50
0
2021-Q1
Decreased
20,731
-48.8%
$1.4M0.0%$63.69
0
2020-Q4
Decreased
40,456
-10.4%
$3.1M0.0%$77.43
0
2020-Q3
Decreased
45,166
-60.0%
$1.9M0.0%$43.42
0
2020-Q2
Increased
112,993
+1.2%
$4.9M0.0%$42.60
27
2020-Q1
Increased
111,670
+8.0%
$3.2M0.0%$28.97
29
2019-Q4
Increased
103,370
+4.1%
$6.6M0.0%$64.20
28
2019-Q3
Increased
99,305
+371.1%
$2.8M0.0%$26.96
42
2019-Q2
Increased
21,080
+31.9%
$559,0000.0%$26.50
31
2019-Q1
New
15,980
-
$293,0000.0%$18.35
32

Other major holders of ARWR: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used